Skip to content

Effects of transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder

Effects of transcranial direct current stimulation (tDCS) on response inhibition and neuronal activity in obsessive-compulsive disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN99571476
Enrollment
44
Registered
2022-03-22
Start date
2022-04-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effects of transcranial direct current stimulation (tDCS) in patients suffering from obsessive-compulsive disorder Mental and Behavioural Disorders

Interventions

tDCS (active condition) vs. sham tDCS (control condition) will be applied in a double-blinded randomized cross-over design. tDCS in the active condition will comprise 20 minutes of anodal tDCS over th

Sponsors

Deutsche Forschungsgemeinschaft
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. MRI compatibility, age 18-65 years, right-handedness 2. OCD according to DSM-V 3. At least a score of 8 in the Y-BOCS scale 4. No additional psychopharmacological medication (e.g. antipsychotic medication) 5. No bipolar disorder, no schizophrenia, no schizo-affective disorder, no posttraumatic stres disorder, no substance abuse (apart from nicotine), no personality disorder

Exclusion criteria

Exclusion criteria: 1. Suicidality 2. Neurological disorder 3. Pregnancy 4. Inability to provide consent 5. No willingness to provide consent after information about the study 6. Medicated with benzodiazepines within the last 24 hours

Design outcomes

Primary

MeasureTime frame
1. Brain activation and connectivity measured during real tDCS and sham tDCS using functional magnetic resonance imaging (fMRI) during two response inhibition tasks. Real tDCS and sham tDCS take place 1 week apart. 2. Inhibition performance measured with two well-established inhibition tasks (Stroop task, Stop-Signal-task) at T0 (i.e., first MRI measurement timepoint) and T1 (i.e., 1 week later).

Secondary

MeasureTime frame
Clinical symptoms assessed with the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) at T0 (i.e., first MRI measurement timepoint) and T1 (i.e., 1 week later)

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 7, 2026